Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Remegal Different Doses in Patients With Refractory Partial Seizures

This study has been completed.
Information provided by (Responsible Party):
Valexfarm Identifier:
First received: July 30, 2010
Last updated: December 5, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)